2Youn Y S,Lee S C,Rhim J W,et al.Early additional immune-modulators for mycoplasma pneumoniae pneumonia in children:an observation study[J].Infect Chemother,2014,46(4):239.
3Ye Q,Xu X J,Shao W X,et al.Mycoplasma pneumoniae infection in children is a risk factor for developing allergic diseases[J].Scientific World Journal,2014,2014:986527.
4Meyer Sauteur P M,Jacobs B C,Spuesens E B,et al.Antibody responses to mycoplasma pneumoniae:role in pathogenesis and diagnosis of encephalitis[J].PLo S Pathog,2014,10(6):e1003983.
5Izumikawa K,Izumikawa K,Takazono T,et al.Clinical features,risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia:a review of the Japanese literature[J].J Infect Chemother,2014,20(3):181.
6Youn YS, Lee KY. Mycoplasma pneumoniae pneumonia in children [J]. Korean J Pediatr, 2012, 55(2): 42-47.
7He Quan. Extrapulmonary mycoplasma infection of clinical analysis [J]. Journal of the Chinese general medicine, 2013, 22(9): 1352-1353.
8Yin Fang-ying, Jiang Wei-dong, Guo Fang. Pediatric pneumonia mycoplasma infection merge heart damage of 35 cases of clinical analysis[J]. China's maternal and child health care, 2007, 11 (2): 188- 189.
9Akihiro T, Kousaku M, Takayuki T, et al. Methylp-rednisolone pulse therapy for refractory mycoplasma in children [J]. Journal of Infection, 2008, 57(3): 223-228.
10Smith LG. Mycoplasma pneumonia and its complications [J]. Infect Dis Clin North Am, 2010, 24 (1): 57-60.
